Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263393 Methods of using(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4 -oxo-1-(2-thiazolyl)- 1,8-naphthyridine-3-carboxylic acid for treatment of cancer
10/22/2009US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection
10/22/2009US20090263388 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
10/22/2009US20090263379 Monoclonal antibodies for inhibition of laminin-8 expression to inhibit human gliomas
10/22/2009US20090263377 Il-32b-targeted diagnosis and therapy
10/22/2009US20090263375 Novel poly(a) polymerase
10/22/2009US20090263367 Composition and method for promoting internal health and external appearance
10/22/2009US20090263364 Method and constructs for delivering double stranded rna to pest organisms
10/22/2009US20090263354 Compositions and siRNAs for inhibiting C/EBPbeta
10/22/2009US20090263353 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
10/22/2009US20090263349 Methods and compositions for inhibiting angiogenesis
10/22/2009US20090263347 Analysis of amino acid copolymer compositions
10/22/2009US20090263345 Otic compositions for the treatment of infections of the internal and external ear in mammals
10/22/2009US20090263341 Soft anticholinergic esters
10/22/2009US20090263340 Cosmetic compositions
10/22/2009US20090263336 Novel pyran derivatives and their preparation
10/22/2009US20090263333 Pharmaceutical compounds and compositions
10/22/2009US20090263327 Minimally invasive physiological function monitoring agents
10/22/2009US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009US20090263321 Compositions and Methods for Treating Post-Operative Pain Using Clonidine and Bupivacaine
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009US20090263319 Methods and compositions for treating postoperative pain comprosing ketorolac
10/22/2009US20090261014 Dispenser For Progestin Used For Acute Maintenance Treatment Of DUB
10/22/2009DE102008020197A1 Schnell benetzbares, Hydrokolloid enthaltendes Material, Verfahren zu dessen Herstellung sowie dessen Verwendung Quickly wettable, hydrocolloid-containing material, process for its preparation and its use
10/22/2009DE102008019907A1 Pyridazinonderivate Pyridazinone derivatives
10/22/2009DE102008019339A1 Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum A composition for medical use, in particular antacid
10/22/2009CA2758829A1 Method of treating demyelinating disease
10/22/2009CA2725441A1 Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
10/22/2009CA2725230A1 Hemifumarate of a pyrazole derivative
10/22/2009CA2723262A1 Compositions and devices for antisepsis and anticoagulation
10/22/2009CA2722308A1 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
10/22/2009CA2721838A1 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
10/22/2009CA2721837A1 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/22/2009CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009CA2721728A1 Treatment of inflammatory bowel disease with 6-mercaptopurine
10/22/2009CA2721722A1 On01910.na enhances chemotherapeutic agent activity in drug-resistant tumors
10/22/2009CA2721670A1 3-phenylpyrazolo[5,1-b]thiazole compound
10/22/2009CA2721666A1 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
10/22/2009CA2721630A1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
10/22/2009CA2721615A1 An inhibitor of anti-apoptotic proteins
10/22/2009CA2721595A1 Polymorphs of hydrochloride salt of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide andmethods of use therefor
10/22/2009CA2721591A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
10/22/2009CA2721586A1 Compositions containing antiviral compounds and methods of using the same
10/22/2009CA2721509A1 Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
10/22/2009CA2721506A1 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants
10/22/2009CA2721467A1 Spirocyclic derivatives as histone deacetylase inhibitors
10/22/2009CA2721457A1 Topical combinations comprising an antimycotic agent and an antiviral agent
10/22/2009CA2721452A1 Bis-aryl compounds for use as medicaments
10/22/2009CA2721434A1 Inhibitors of phosphatidylinositol 3-kinase
10/22/2009CA2721399A1 Substituted tetracycline compounds
10/22/2009CA2721366A1 Stimulation of an immune response by enantiomers of cationic lipids
10/22/2009CA2721360A1 Methods and compositions for treating and identifying compounds to treat age-related macular degeneration
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2721333A1 Novel lipid formulations for nucleic acid delivery
10/22/2009CA2721279A1 Steroid nebuliser formulation
10/22/2009CA2721269A1 Compounds and methods for altering bone growth
10/22/2009CA2721240A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
10/22/2009CA2721229A1 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
10/22/2009CA2721203A1 Inhibitors of protein phosphatase-1 and uses thereof
10/22/2009CA2721191A1 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/22/2009CA2721032A1 Anti-areg/hb-egf antibodies and treatment
10/22/2009CA2721019A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/22/2009CA2721007A1 Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
10/22/2009CA2720990A1 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009CA2720851A1 Oral pharmaceutical compositions in a molecular solid dispersion
10/22/2009CA2720849A1 High density compositions containing posaconazole and formulations comprising the same
10/22/2009CA2720672A1 Tricyclic antibiotics
10/22/2009CA2720671A1 Compositions and methods for preparing and using same
10/22/2009CA2720646A1 Nitrated hydrocarbons, derivatives, and processes for their manufacture
10/22/2009CA2720559A1 Pyridazinone glucokinase activators
10/22/2009CA2720542A1 Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof
10/22/2009CA2720524A1 Pyrrolidinone glucokinase activators
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/22/2009CA2719789A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009CA2719785A1 Ether benzylidene piperidine aryl carboxamide compounds
10/22/2009CA2719784A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds
10/22/2009CA2718538A1 Quinoline derivatives as axl kinase inhibitors
10/22/2009CA2717087A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides
10/22/2009CA2716886A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds
10/22/2009CA2714219A1 Kappa opioid receptor ligands
10/22/2009CA2700736A1 Methods and compositions for treating post-operative pain comprising a local anesthetic
10/22/2009CA2700586A1 Clonidine formulations in a biodegradable polymer carrier
10/22/2009CA2700578A1 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009CA2700561A1 Medical devices and methods including polymers having biologically active agents therein
10/22/2009CA2700389A1 Methods and compositions for treating post-operative pain comprising clonidine
10/22/2009CA2700196A1 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
10/22/2009CA2700002A1 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009CA2693001A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/21/2009EP2110384A1 Hepatopoietin and use thereof
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2110377A1 Spirocyclic derivatives as histone deacetylase inhibitors
10/21/2009EP2110375A1 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/21/2009EP2110374A1 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
10/21/2009EP2110141A1 Protective agent for retinal nerve or optic nerve
10/21/2009EP2110138A1 Dosages for treatment of anti-erbB2 antibodies
10/21/2009EP2110134A1 Cocoa extract compounds and methods for making and using the same
10/21/2009EP2110131A1 Anti-tumor composition comprising tissue-accumulating chitosan gel
10/21/2009EP2110130A1 Pharmaceutical use of 6-mercaptopurine
1 ... 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 ... 7860